Method for determining rabeprazole sodium and impurities thereof by using high performance liquid chromatography

A technology of high performance liquid chromatography and rabeprazole sodium, which is applied in the field of high performance liquid chromatography for the determination of rabeprazole sodium and its impurities, can solve problems such as affecting the purity and quality of medicines, and achieves convenient quality detection and monitoring, Guaranteed sensitive and reproducible results

CN112834628AInactive Publication Date: 2021-05-25YANGTZE RIVER PHARM GRP CO LTD
10 Cites 1 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Publication Date
2021-05-25
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses a method for determining rabeprazole sodium and impurities thereof by using high performance liquid chromatography. A mobile phase of the method comprises a mobile phase A and a mobile phase B, the mobile phase A is a phosphate buffer solution, the mobile phase B is acetonitrile, rabeprazole sodium and nine impurities thereof can be effectively separated in a high performance liquid chromatogram by adopting a gradient elution mode, and the method is good in specificity, high in sensitivity and high in accuracy; and quality detection and monitoring of the rabeprazole sodium and the preparation thereof are facilitated.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the field of drug analysis, in particular to a method for measuring rabeprazole sodium and its impurities by high performance liquid chromatography. Background technique

[0002] Rabeprazole sodium (Sodium Reheprazole), is a new generation of proton pump inhibitors developed by Japan's Eisai Company. It is the latest benzimidazole substitute after lansoprazole and omeprazole. The endoplasmic pump has a strong inhibitory effect. First launched in Japan in 1997, the dosage form is oral solid preparation. The drug is clinically applicable to gastric ulcer, duodenal ulcer, gastroesophageal reflux disease, Helicobacter pylori, Zoller-Ellison syndrome, etc., while rabeprazole sodium for injection is suitable for treatment when oral medication cannot be used. alternative therapy.

[0003] Rabeprazole sodium chemical name: 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole sodium Salt, molecular formula:...

Examples

Embodiment 1

[0060] Chromatographic column: Phenomenex Gemini C18, 4.6×250mm, 5μm

[0061] Mobile phase: Mobile phase A: Phosphate buffer (pH7.0) [take 6.8g of potassium dihydrogen phosphate, 1.164g of sodium hydroxide, add water to dissolve and dilute to 1000ml]

[0062] Mobile Phase B: Acetonitrile

[0063] Gradient elution according to the table

[0064]

[0065]

[0066] Column temperature: 30°C Flow rate: 1.0ml / min

[0067] Detection wavelength: 286nm

[0068] Diluent: 0.001mol / L sodium hydroxide solution-acetonitrile (volume ratio 1:1).

[0069] Preparation of positioning solution: take each impurity reference substance, and use diluent to make a solution containing about 125 μg of impurities per 1 ml, as each impurity positioning solution.

[0070] Preparation of mixed solution of rabeprazole sodium and impurities: take about 25 mg of rabeprazole sodium reference substance, accurately weigh it, put it in a 25ml measuring bottle, accurately add 200 μl of the above-mentioned...

Embodiment 2

[0078] Example 2 sample detection

[0079] The present inventor tests rabeprazole sodium for injection and rabeprazole sodium enteric-coated tablets to investigate the actual sample detection capability of the method.

[0080] Blank excipient solution of rabeprazole sodium for injection: take mannitol and edetate disodium mixed excipients, weigh them accurately, add diluent to dissolve and make a 0.8mg / ml solution.

[0081] Need testing solution: take appropriate amount of content of rabeprazole sodium for injection, weigh accurately, add diluent to dissolve and dilute to make 1mg / ml solution.

[0082] Rabeprazole Sodium Enteric-Coated Tablets Test Solution: Take 20 pieces of samples, grind them finely, accurately weigh an appropriate amount (approximately equivalent to 20 mg of Rabeprazole Sodium), put them in a 20ml measuring bottle, add an appropriate amount of acetonitrile to dissolve and constant volume , Shake well, pass through a 0.45μm membrane filter, and use it as t...

Embodiment 3

[0085] Embodiment 3 limit of quantification and limit of detection test

[0086] Each impurity positioning solution and rabeprazole sodium reference substance solution (that is, accurately weigh an appropriate amount of rabeprazole sodium reference substance, add diluent to dissolve and dilute to make a 1mg / ml solution) are diluted step by step with diluent, Precisely measure 20 μl of solutions with different concentrations, inject them into the liquid chromatograph respectively, and record the chromatograms. The concentration when the signal-to-noise ratio is about 10:1 is the limit of quantification; the concentration when the signal-to-noise ratio is about 3:1 is the limit of detection.

[0087] The results are shown in the table below

[0088]

[0089]